TickerSpark Feed

consumer health

Everything tagged "consumer health" across the TickerSpark archives.

Hims & Hers Health (HIMS): Growth Is Real, But Execution Matters

Hims & Hers is scaling fast, with Q2 revenue up 38% and subscribers up 19%, but profitability, leverage, and regulatory risk keep the story from being a simple growth call. The stock still earns a Buy, though investors need to watch cash flow and margin pressure closely.

Nov 9, 2026·20 MIN

Healthcare Drug Manufacturers - Specialty & Generic Growth

Research ReportKVUE

Kenvue (KVUE): Improving Momentum, But Still a Hold

Kenvue is showing better sales, margin, and EPS momentum, but the stock still looks fairly valued rather than compellingly cheap. Its defensive brands and cash generation support the case, while leverage and execution risk keep the rating at Hold.

Oct 31, 2026·19 MIN

Consumer Defensive Household & Personal Products Consumer Health

On-Demand Research

Need research on a stock not covered here?

Generate AI research on any ticker — grades, price targets, and full analysis in minutes.

Open the Generator

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverPSTG

▲9.14%

Pure Storage Inc. · $86.22

Hims & Hers Health (HIMS): Growth Is Real, But Execution Matters

Kenvue (KVUE): Improving Momentum, But Still a Hold

Need research on a stock not covered here?

A new stock idea, every evening.

Stock research for every investor